Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity
Acta Ophthalmologica · 2023
DOI: 10.1111/aos.15651 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Acta Ophthalmologica, 2023. Verfasst von Cris Martin P Jacoba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Retina. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Medical Research Council, Philippine Council for Health Research and Development.
Abstract (Originalsprache)
Purpose
To compare diabetic retinopathy (DR) severity identified on handheld retinal imaging with ultrawide field (UWF) images.
Methods
Mydriatic images of 225 eyes of 118 diabetic patients were prospectively imaged with the Aurora (AU) handheld retinal camera [5‐field protocol (macula‐centred, disc‐centred, temporal, superior, inferior)] and compared with UWF images. Images were classified based on the international classification for DR. Sensitivity, specificity, kappa statistics (K/Kw) were calculated on an eye and person‐level.
Results
Distribution of DR severity by AU/UWF images (%) by eye was no DR 41.3/36.0, mild non‐proliferative DR (NPDR) 18.7/17.8, moderate 10.2/10.7, severe 16.4/15.1, proliferative DR (PDR) 13.3/20.4. Agreement between UWF and AU was exact in 64.4%, within 1‐step 90.7%, k = 0.55 (95% CI:0.45–0.65), and kw = 0.79 (95% CI:0.73–0.85) by eye, and exact in 68%, within 1‐step 92.9%, k = 0.58 (95% CI:0.50–0.66), and kw = 0.76 (95% CI:0.70–0.81) by person. Sensitivity/specificity for any DR, refDR, vtDR and PDR were as follows: 0.90/0.83, 0.90/0.97, 0.82/0.95 and 0.69/1.00 by person and 0.86/0.90, 0.84/0.98, 0.75/0.95 and 0.63/0.99 by eye. Handheld imaging missed 37% (17/46) eyes and 30.8% (8/26) persons with PDR. Only 3.9% (1/26) persons or 6.5% (3/46) eyes with PDR were missed if a referral threshold of moderate NPDR was used.
Conclusions
Data from this study show that comparing UWF and handheld images, when PDR was the referral threshold for handheld devices, 37.0% of eyes or 30.8% of patients with PDR were missed. Due to the identification of neovascular lesions outside of the handheld fields, lower referral thresholds are needed if handheld devices are used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts, USA.
- Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
- Philippine Eye Research Institute, University of the Philippines, Manila, Philippines.
- Centre for Public Health, Queen's University Belfast, Belfast, UK.
- Eye and Vision Institute, The Medical City, Metro Manila, Philippines.
ORCID-Profile: Tunde Peto, Paolo S Silva
Förderung
- NIDDK NIH HHS
- Medical Research Council
- Philippine Council for Health Research and Development
Zitieren
APA
Jacoba, C. M. P., Salongcay, R. P., Aquino, L. A. C., Salva, C. M. G., Saunar, A. V., Alog, G. P., Peto, T., & Silva, P. S. (2023). Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity. Acta Ophthalmologica. https://doi.org/10.1111/aos.15651
Vancouver
Jacoba CMP, Salongcay RP, Aquino LAC, Salva CMG, Saunar AV, Alog GP, et al. Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity. Acta Ophthalmologica. 2023. doi:10.1111/aos.15651
BibTeX
@article{Jacoba2023,
author = {Jacoba, Cris Martin P and Salongcay, Recivall P and Aquino, Lizzie Anne C and Salva, Claude Michael G and Saunar, Aileen V and Alog, Glenn P and Peto, Tunde and Silva, Paolo S},
title = {Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity},
journal = {Acta Ophthalmologica},
year = {2023},
doi = {10.1111/aos.15651}
}
EUVIMED